首页> 美国卫生研究院文献>Acta Naturae >Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG
【2h】

Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG

机译:靶向光毒性蛋白DARPinminiSOG处理的人乳腺癌细胞上HER2受体的内在化和再循环

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Design and evaluation of new high-affinity protein compounds that can selectively and efficiently destroy human cancer cells are a priority research area in biomedicine. In this study we report on the ability of the recombinant phototoxic protein DARPin-miniSOG to interact with breast adenacarcinoma human cells overexpressing the extracellular domain of human epidermal growth factor receptor 2 (HER2). It was found that the targeted phototoxin DARPin-miniSOG specifically binds to the HER2 with following internalization and slow recycling back to the cell membrane. An insight into the role of DARPin-miniSOG in HER2 internalization could contribute to the treatment of HER2-positive cancer using this phototoxic protein.
机译:可以选择性和有效破坏人类癌细胞的新型高亲和力蛋白化合物的设计和评估是生物医学领域的重点研究领域。在这项研究中,我们报告了重组光毒性蛋白DARPin-miniSOG与过表达人表皮生长因子受体2(HER2)胞外域的乳腺癌患者的相互作用。发现靶向的光毒素DARPin-miniSOG与HER2特异性结合,随后被内在化并缓慢循环回到细胞膜。深入了解DARPin-miniSOG在HER2内化中的作用可能有助于使用这种光毒性蛋白治疗HER2阳性癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号